Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytogam for PRA Reduction in Sensitized Renal Transplant Candidates
NCT00784979Phase 4Completed
- Sponsor
- Tampa General Hospital
- Start
- Jan 2002
- Primary completion
- Dec 2010
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 4 trial of IgPro10 in end stage renal disease (ESRD), sponsored by Tampa General Hospital. Started Jan 2002; status: completed.
02
Drugs
IgPro10
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT00784979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00784979.